Intravenous Alternatives to Augmentin (Amoxicillin/Clavulanate)
Ampicillin/sulbactam is the most appropriate intravenous alternative to Augmentin (amoxicillin/clavulanate) with a similar spectrum of activity and clinical efficacy. 1
Primary IV Alternatives to Augmentin
First-Line Options:
Ampicillin/sulbactam (Unasyn)
Piperacillin/tazobactam
Alternative Options:
- Ceftriaxone + metronidazole (for mixed infections requiring anaerobic coverage) 2, 4
- Ertapenem (1g IV daily) - reserve for more resistant infections 2
Clinical Decision Algorithm
When selecting an IV alternative to Augmentin, consider:
Infection type and severity:
- For mild-moderate infections: Ampicillin/sulbactam
- For severe infections or suspected resistant pathogens: Piperacillin/tazobactam
Suspected pathogens:
Patient factors:
Special Considerations
Penicillin allergy: For patients with non-severe penicillin allergy, ceftriaxone may be used. For severe allergies, consider fluoroquinolones (e.g., levofloxacin, moxifloxacin) or other non-beta-lactam alternatives 2
Pediatric patients: Ampicillin/sulbactam is approved for children ≥1 year at 300 mg/kg/day divided every 6 hours (200 mg ampicillin + 100 mg sulbactam per kg per day) 1
Renal dosing adjustments for ampicillin/sulbactam: 1
- CrCl ≥30 mL/min: 1.5-3g q6-8h
- CrCl 15-29 mL/min: 1.5-3g q12h
- CrCl 5-14 mL/min: 1.5-3g q24h
Important Caveats
Avoid unnecessary combination therapy with antibiotics from the same class as this increases adverse effects without providing additional benefit 4
When administering ampicillin/sulbactam with aminoglycosides, administer separately due to potential inactivation 1, 3
Duration of therapy should generally not exceed 7-14 days for most infections, with shorter durations (3-5 days) appropriate for many uncomplicated infections with adequate source control 2